Overview

Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma

Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
Evaluate atrophogenic potential of long-term use of Tri-Luma Cream on facial Melasma through biopsy examination.
Phase:
Phase 4
Details
Lead Sponsor:
Galderma Laboratories, L.P.
Treatments:
Fluocinolone Acetonide
Hydroquinone
Tretinoin